Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Assist Reprod Genet ; 39(1): 75-84, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34642876

RESUMO

PURPOSE: During fertilisation, female and male pronuclei (PNs) migrate to the centre of the ooplasm, juxtapose, and break down synchronously in preparation for the first mitosis. While PN non-juxtaposition and PN breakdown (PNBD) asynchrony are occasionally observed, their developmental implications remain uncertain. This study investigated the possible relationships among the two phenomena, preimplantation development patterns, and live birth rates in single blastocyst transfers. METHODS: A total of 1455 fertilised oocytes cultured in a time-lapse incubator were retrospectively analysed. Fertilised oocytes were divided into four groups according to the presence of PN juxtaposition and breakdown synchrony. The relationships of abnormal PN behaviour with embryo morphokinetics, blastocyst formation, and live birth were evaluated. RESULTS: PN non-juxtaposition and asynchrony were observed in 1.9% and 1.0% of fertilised oocytes, respectively. The blastocyst cryopreservation rates in the synchronous-non-juxtaposed and asynchronous-non-juxtaposed groups were significantly lower than that in the synchronous-juxtaposed group. The rates of clinical pregnancy, ongoing pregnancy, and live birth were comparable among the groups. Non-juxtaposition was significantly associated with increased trichotomous cleavage at the first cytokinesis (P < 0.0001) and an increase in the time interval from PNBD to first cleavage (P < 0.0001). Furthermore, asynchronous PNBD was significantly correlated with increased rapid cleavage at the first cytokinesis (P = 0.0100). CONCLUSION: Non-juxtaposition and asynchronous PNBD is associated with abnormal mitosis at the first cleavage and impaired preimplantation development. However, embryos displaying abnormal PNBD may develop to blastocyst stage and produce live births, suggesting blastocyst transfer as a more appropriate culture strategy.


Assuntos
Terapia de Substituição Mitocondrial/instrumentação , Análise Espaço-Temporal , Adulto , Pesquisas com Embriões , Desenvolvimento Embrionário/fisiologia , Feminino , Humanos , Masculino , Terapia de Substituição Mitocondrial/métodos , Terapia de Substituição Mitocondrial/estatística & dados numéricos , Estudos Retrospectivos
2.
J Reprod Dev ; 59(6): 599-603, 2013 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-23979397

RESUMO

Somatic cell nuclear transfer (SCNT) is a useful technique for creating pig strains that model human diseases. However, production of numerous cloned disease model pigs by SCNT for large-scale experiments is impractical due to its complexity and inefficiency. In the present study, we aimed to establish an efficient procedure for proliferating the diabetes model pig carrying the mutant human hepatocyte nuclear factor-1α gene. A founder diabetes transgenic cloned pig was generated by SCNT and treated with insulin to allow for normal growth to maturity, at which point epididymal sperm could be collected for cryopreservation. In vitro fertilization and intrafallopian insemination using the cryopreserved epididymal sperm resulted in diabetes model transgenic offspring. These results suggest that artificial reproductive technology using cryopreserved epididymal sperm could be a practical option for proliferation of genetically modified disease model pigs.


Assuntos
Criopreservação/veterinária , Diabetes Mellitus/veterinária , Modelos Animais de Doenças , Fertilização in vitro/veterinária , Inseminação Artificial/veterinária , Espermatozoides , Doenças dos Suínos/genética , Animais , Animais Geneticamente Modificados , Clonagem de Organismos/veterinária , Diabetes Mellitus/tratamento farmacológico , Diabetes Mellitus/genética , Feminino , Fator 1-alfa Nuclear de Hepatócito/genética , Fator 1-alfa Nuclear de Hepatócito/metabolismo , Humanos , Hipoglicemiantes/uso terapêutico , Japão , Masculino , Mutação , Técnicas de Transferência Nuclear/veterinária , Gravidez , Sus scrofa , Suínos , Doenças dos Suínos/tratamento farmacológico
3.
PLoS One ; 8(4): e61900, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23626746

RESUMO

BACKGROUND: The development and validation of stem cell therapies using induced pluripotent stem (iPS) cells can be optimized through translational research using pigs as large animal models, because pigs have the closest characteristics to humans among non-primate animals. As the recent investigations have been heading for establishment of the human iPS cells with naïve type characteristics, it is an indispensable challenge to develop naïve type porcine iPS cells. The pluripotency of the porcine iPS cells can be evaluated using their abilities to form chimeras. Here, we describe a simple aggregation method using parthenogenetic host embryos that offers a reliable and effective means of determining the chimera formation ability of pluripotent porcine cells. METHODOLOGY/SIGNIFICANT PRINCIPAL FINDINGS: In this study, we show that a high yield of chimeric blastocysts can be achieved by aggregating the inner cell mass (ICM) from porcine blastocysts with parthenogenetic porcine embryos. ICMs cultured with morulae or 4-8 cell-stage parthenogenetic embryos derived from in vitro-matured (IVM) oocytes can aggregate to form chimeric blastocysts that can develop into chimeric fetuses after transfer. The rate of production of chimeric blastocysts after aggregation with host morulae (20/24, 83.3%) was similar to that after the injection of ICMs into morulae (24/29, 82.8%). We also found that 4-8 cell-stage embryos could be used; chimeric blastocysts were produced with a similar efficiency (17/26, 65.4%). After transfer into recipients, these blastocysts yielded chimeric fetuses at frequencies of 36.0% and 13.6%, respectively. CONCLUSION/SIGNIFICANCE: Our findings indicate that the aggregation method using parthenogenetic morulae or 4-8 cell-stage embryos offers a highly reproducible approach for producing chimeric fetuses from porcine pluripotent cells. This method provides a practical and highly accurate system for evaluating pluripotency of undifferentiated cells, such as iPS cells, based on their ability to form chimeras.


Assuntos
Blastocisto/fisiologia , Quimera/embriologia , Células-Tronco Pluripotentes Induzidas/fisiologia , Mórula/fisiologia , Partenogênese/genética , Animais , Blastocisto/citologia , Diferenciação Celular , Células Cultivadas , Quimera/crescimento & desenvolvimento , Feminino , Fertilização in vitro , Feto , Humanos , Células-Tronco Pluripotentes Induzidas/citologia , Masculino , Mórula/citologia , Oócitos/fisiologia , Técnicas de Reprodução Assistida , Suínos
4.
Biol Reprod ; 87(6): 133, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23053438

RESUMO

In vitro matured (IVM) oocytes have been used to create genetically modified pigs for various biomedical purposes. However, porcine embryos derived from IVM oocytes are very cryosensitive. Developing improved cryopreservation methods would facilitate the production of genetically modified pigs and also accelerate the conservation of genetic resources. We recently developed a novel hollow fiber vitrification (HFV) method; the present study was initiated to determine whether this new method permits the cryopreservation of IVM oocyte-derived porcine embryos. Embryos were created from the in vitro fertilization of IVM oocytes with frozen-thawed sperm derived from a transgenic pig carrying a humanized Kusabira-Orange (huKO) gene. Morula-stage embryos were assigned to vitrification and nonvitrification groups to compare their in vitro and in vivo developmental abilities. Vitrified morulae developed to the blastocyst stage at a rate similar to that of nonvitrified embryos (66/85, 77.6% vs. 67/84, 79.8%). Eighty-eight blastocysts that developed from vitrified morulae were transferred into the uteri of three recipient gilts. All three became pregnant and produced a total of 17 piglets (19.3%). This piglet production was slightly lower, albeit not significantly, than that of the nonvitrification group (27/88, 30.7%). Approximately half of the piglets in the vitrification (10/17, 58.8%) and nonvitrification (15/27, 55.6%) groups were transgenic. There was no significant difference in the growth rates among the piglets in the two groups. These results indicate that the HFV method is an extremely effective method for preserving cryosensitive embryos such as porcine in vitro maturation/fertilization-derived morulae.


Assuntos
Animais Geneticamente Modificados/fisiologia , Criopreservação/veterinária , Fertilização in vitro/veterinária , Técnicas de Maturação in Vitro de Oócitos/veterinária , Mórula , Sus scrofa/fisiologia , Vitrificação , Animais , Animais Geneticamente Modificados/genética , Animais Geneticamente Modificados/crescimento & desenvolvimento , Blastocisto/metabolismo , Cruzamentos Genéticos , Criopreservação/instrumentação , Ectogênese , Implantação do Embrião , Perda do Embrião/prevenção & controle , Transferência Embrionária/efeitos adversos , Transferência Embrionária/veterinária , Feminino , Fertilização in vitro/efeitos adversos , Nascido Vivo , Proteínas Luminescentes/genética , Proteínas Luminescentes/metabolismo , Masculino , Mórula/citologia , Mórula/metabolismo , Gravidez , Distribuição Aleatória , Preservação do Sêmen/efeitos adversos , Sus scrofa/genética , Sus scrofa/crescimento & desenvolvimento , Aumento de Peso , Proteína Vermelha Fluorescente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...